Methuosis, Alkaliptosis, and Oxeiptosis and Their Significance in Anticancer Therapy

Elżbieta Bartoszewska1,2, Kamila Florek1,2, Karol Zagórski1,2

  • 1Faculty of Medicine, Wroclaw Medical University, L. Pasteura 1, 50-367 Wroclaw, Poland.

Cells
|January 8, 2025
PubMed

Insights

Exploring novel cell death pathways like methuosis, alkaliptosis, and oxeiptosis is key for developing new cancer treatments. Understanding these mechanisms offers new avenues for cancer management and therapy.

Area of Science:

  • Cell Biology
  • Oncology
  • Molecular Mechanisms

Background:

  • Cell death mechanisms are crucial for cancer therapy development.
  • While many cell death pathways are known, newer ones require further investigation.
  • Methuosis, alkaliptosis, and oxeiptosis represent emerging areas in cell death research.

Purpose of the Study:

  • To review and summarize current data on methuosis, alkaliptosis, and oxeiptosis.
  • To elucidate the role of these specific cell death pathways in cancer treatment.
  • To highlight the unique molecular and cellular characteristics of these lesser-known death mechanisms.

Main Methods:

  • Literature review and data synthesis.
  • Analysis of molecular pathways involved in methuosis, alkaliptosis, and oxeiptosis.
  • Evaluation of the potential therapeutic applications of these cell death modalities in oncology.

Main Results:

  • Methuosis, alkaliptosis, and oxeiptosis are distinct cell death pathways with unique molecular underpinnings.
  • Each pathway exhibits specific cellular outcomes relevant to cancer biology.
  • Understanding these mechanisms provides insights into cancer cell vulnerabilities.

Conclusions:

  • Methuosis, alkaliptosis, and oxeiptosis offer novel targets for cancer therapy.
  • Further research into these pathways can enhance our understanding of cell death.
  • These findings open new therapeutic opportunities for neoplasm management.

Related Concept Videos

Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
131
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K